Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SynKIR-110 |
Synonyms | |
Therapy Description |
SynKIR-110 comprises autologous T-lymphocytes engineered to express a killer cell immunoglobulin-like receptor (KIR)-based chimeric antigen receptor (CAR) targeting MSLN, which potentially induce killing of tumor cells expressing MSLN (NCI Drug Dictionary). |